U.S. federal trademark · Serial No. 86136758 · Reg. No. 4804722
medical and scientific research for the purpose of evaluating the relative benefits of various clinical management strategies and the pathogenesis of severe sepsis, characterizing the clinical aspects of sepsis related to various potential biological threats, improving outcomes for severe sepsis in austere environments, investigating the immunopathogenesis and long-term sequelae of infectious etiologies, especially hemorrhagic fevers, and augmenting the capability to gather important clinical data in outbreak settings of severe emerging disease
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.